Story thread · 2 reports / 2 sources
JPMorgan sees 100% upside in overlooked cancer drug stock
thestreet.com · 3h
The bank just put a big number on a small biotech company, and the target rests on a newly launched drug.
First report: This cancer drug stock could double as its treatment hits the market, JPMorgan says — cnbc.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.